Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MDMA to establish ethics code

This article was originally published in The Gray Sheet

Executive Summary

Medical Device Manufacturers Association is developing a code-of-conduct similar to those for PhRMA and AdvaMed, MDMA Chairman Chris Chavez, CEO of Advanced Neuromodulation Systems, reports at a Morgan Stanley healthcare conference in Miami. The National Electrical Manufacturers Association's code of ethics was approved at the end of 2004; AdvaMed's has been in effect for two years (1"The Gray Sheet" Dec. 6, 2004, p. 12)...

You may also be interested in...



NEMA Code Clarifies Ethics Of R&D Grants, Drops “Entertainment” Entirely

The National Electrical Manufacturers Association's new code of ethics endorses strict parameters for device company allocation of research funds to healthcare providers

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022074

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel